Dr Drew is Cancer Free!

In the past few weeks Dr. Drew Pinsky, the host of HLN’s Dr. Drew on Call, has begun talking about his battle with prostate cancer. “While many of you were celebrating the Fourth of July, I was at home on my couch recovering from a robotic prostatectomy. Four hours of surgery had left me in great pain, without an appetite, and in need of help to get up and lie down. But I was cancer-free for the first time in at least two years.”

According to an essay on the HLN’s Network Blog, it was only after his wife, Susan, pressured him to get a check up, that it was noticed that Pinsky’s Prostate Specific Antigen (PSA) levels had gone up from a “one” to a “four”. While this was still considered in the “normal” range an ultrasound was performed and revealed that the central lobe of his prostate was bigger than it should have been. Pinsky was then diagnosed with prostatitis or inflammation of the prostate.

Based on his PSA levels and this increase in the size of his prostate, Pinsky’s doctor strongly suggested that a biopsy be performed. This biopsy revealed that he definitely had prostate cancer. The next step was a phase of Active Surveillance, in which the tumor was monitored over the course of more than a year. Finally after a third biopsy, about two to three months ago, it was noticed that the tumor had begun to change shape, and as a result was time to have it removed.

Pinsky states, that he is discussing his battle to help make men aware. It is his goal to inform men that most are likely to get prostate cancer and that they should not panic if and when that time comes. “I’m grateful this was a detectable and  survivable cancer. I’m pleased that the judgement and intuition of my physicians were spot-on every step of the way.”

We at the International Prostate Cancer Foundation commend Dr Drew Pinsky for his bravery and willingness to go public about his battle, as putting faces on this disease is key in creating awareness.

Dr Drew Pinsky’s Top Ten Things to Know about Prostate Cancer

  • Prostate cancer is a complex disease.
  • It behaves differently at different ages.
  • PSA screening is complicated and controversial.
  • If your doctor recommends a biopsy or ultrasound, don’t refuse simply because it involves a sensitive part of your body.
  • If the results show the presence of cancer, don’t panic.
  • Time is on your side. Don’t rush decisions about radiation or surgery.
  • Many men can opt for active surveillance, watching the prostate over a period of months or years.
  • There isn’t a by-the-book, one-size-fits-all treatment.
  • Trust your doctors’ judgment and instincts. They have seen thousands of cases.
  • You’re seeing your first case, and it’s you.

Dr. Vipul Patel on Fox 35!

In consideration of Prostate Awareness Month, Dr. Vipul Patel, founder of the International Prostate Cancer Foundation, was on Fox 35’s Healthy Housecalls segment on Monday, September 9, 2013. Topics discussed include the Prostate Cancer Screening, a cancer fighting diet, and much more. Check out the video below for all of the Prostate Health tips.

Keep Your Knowledge Current! – New Guidelines for Prostate Cancer Screening

Keep Your Knowledge Current! – New Guidelines for Prostate Cancer Screening

WEB ONLY iStock_000008787577Small

Florida Hospital Cancer Institute has released new recommendations for prostate cancer screening.

In line with the efforts of the International Prostate Cancer Foundation, the FHCI is dedicated to providing patients with the latest treatments and technologies, managed by an experienced, knowledgeable team that focuses on delivering patients the most positive outcomes possible.

As the largest cancer center in Central Florida, recognized worldwide for its comprehensive, state-of-the-art care and reputation as a destination cancer care facility… their expertise should not go ignored!

Florida Hospital Cancer Institute Recommendations for Prostate Cancer Screening*

  • At age 40 men with greater than 10-15 year life expectancy should be risk stratified and considered for Prostate Cancer Screening.  
  • Doctors should start conversing with men about the potential benefits, uncertainties, and risks of Prostate Cancer Screening in the following risk categories:
    1. Very high risk – (men with more than one first degree relative) begin the conversation at age 40.
    2. High risk – (men of African American descent and/or those who have a single first degree relative – father, brother or son diagnosed with prostate cancer before age 65) begin the conversation at age 45.
    3. Average risk – begin conversation at age 50.
  •  Screening should include the PSA blood test and Digital Rectal Exam.
  • Men with less than 10-15 year life expectancy should not be offered Prostate Cancer Screening.

The exact interval (yearly, biennial, or every 4 years) of subsequent Prostate Cancer Screenings are still uncertain and the pros and cons of future screening intervals should be discussed with each patient.

*These recommendations are adopted based upon the guidance of our FHCI expert panel and with consideration of the American Cancer Society Recommendations on Prostate Cancer Screening and the American Urological Association (AUA) Guideline.

Ranked among the top five in the nation for robotic gynecologic-oncology surgeries and the world leader in robotic prostatectomies using the da Vinci® Surgical System, the FHCI performs more than 8,000 cancer surgeries performed annually.

The Florida Hospital Cancer Institute is accredited as a Community Comprehensive Cancer Center by the American College of Surgeons Commission on Cancer and is recognized by the American Society of Clinical Oncology for its clinical research. They strive and succeed in maintaining research affiliations with the National Cancer Institute, Sarah Cannon Research Institute and many other health care institutions and organizations.

For more information on the FHCI we invite you to visit their website:  https://www.floridahospitalcancer.com/about-us

Orlando Sentinel features Dr. Patel & The Real Reason for PSA Screening

Being advocates for awareness & knowledge, the International Prostate Cancer Foundation shares with you opposing opinions in the fight against cancer with the belief that as individuals we have the right to be fully informed.


Just recently, FOX 35 covered the lead story in the Orlando Sentinel highlighting the new “truths” behind various cancer-screening tests including those for breast, prostate, colon, lung and cervical cancer. While we at the IPCF are strong proponents of screening, a growing body of counterintuitive evidence is emerging and we encourage you to be aware of both sides as you define your own stance. As the debate develops some argue that certain cancers, regardless of screening & detection, are cancers that men and women die with, not of.

Our founder, Dr. Vipul Patel has expressed “… what is lost in the debate is that we’re taking away a man’s right to know…”.

Apart from whether screening & detection offer an indisputable road to a cure, ask yourself the value you place on simply having – clear knowledge & control of your health and options.

Read the full Orlando Sentinel article and form your own opinion!

A Celebration of Collaboration – Joining forces with Sanford-Burnham to develop better tests – $60,000 Postdoctoral Grant!!


On May 10, the International Prostate Cancer Foundation awarded Ranjan Perera, Ph.D., scientific director of analytical genomics and bioinformatics at the Sanford-Burnham Lake Nona campus, $60,000 to fund a postdoctoral fellow in Dr. Perera’s lab.


Sanford-Burnham can really make an impact in the field,” said our founder Dr. Vipul Patel, as he acknowledged Dr. Perera’s work to identify molecular markers for prostate cancer. With a shared goal to develop better diagnoses and treatments, this postdoc grant is only the first step in a long and mutually beneficial partnership between us here at the International Prostate Cancer Foundation and the great minds at Sanford-Burnham.

In Sanford-Burnham Lake Nona labs, Dr. Perera and his team are currently working on early prognostic markers for prostate cancer. The goal is to be able to diagnose prostate cancer earlier, through a simple blood test instead of an invasive biopsy. “This research is urgently needed as professionals from all aspects of the field have been calling for these molecular markers. Not just for prostate cancer, but other malignant tumors as well,” explained Perera.


As Dr. Patel pointed out during the ceremony, “We at Florida Hospital have operated on thousands of prostate cancer patients with various states of disease. We have a large database and a diverse pool of patient samples while Sanford-Burnham has deep basic medical research expertise.” When clinicians and medical researchers work together new therapies and diagnostic tools can be developed more rapidly.

We encourage you to read more about Dr. Perera’s research here & visit Sanford & Burnham’s blog for their full take on the event.

For full coverage and ceremony photos visit the International Prostate Cancer Foundation on Facebook.